SHELLEY SCHULER: Open Payments
NPI 1861653214 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,259 in 94 payments from 15 companies in 2025. Trend: 2023 $2,598 · 2024 $4,460 · 2025 $2,259
Food & beverage: $2,159Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $526 |
| ABBVIE INC. | 17 | $378 |
| Janssen Biotech, Inc. | 7 | $266 |
| Arcutis Biotherapeutics, Inc. | 7 | $184 |
| UCB, Inc. | 8 | $154 |
| E.R. Squibb & Sons, L.L.C. | 11 | $154 |
| Regeneron Healthcare Solutions, Inc. | 6 | $118 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $114 |
| Lilly USA, LLC | 5 | $94 |
| Incyte Corporation | 3 | $67 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Zoryve, Bimzelx, Sotyktu, LIBTAYO, TALTZ.
Industry payments across KY — which companies pay providers there.
